Euro-Med Laboratories Phils Inc

PSE:EURO Philippines Pharmaceuticals
Market Cap
$164.93
₱9.67K PHP
Market Cap Rank
#49853 Global
#128 in Philippines
Share Price
₱1.01
Change (1 day)
-1.94%
52-Week Range
₱0.81 - ₱1.10
All Time High
₱3.22
About

Euro-Med Laboratories Phils Inc operates in Pharmaceuticals.

Euro-Med Laboratories Phils Inc - Asset Resilience Ratio

Latest as of December 2022: 1.89%

Euro-Med Laboratories Phils Inc (EURO) has an Asset Resilience Ratio of 1.89% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
₱190.60 Million
Cash + Short-term Investments
Total Assets
₱10.06 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2022)

This chart shows how Euro-Med Laboratories Phils Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Euro-Med Laboratories Phils Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₱0.00 0%
Short-term Investments ₱190.60 Million 1.89%
Total Liquid Assets ₱190.60 Million 1.89%

Asset Resilience Insights

  • Limited Liquidity: Euro-Med Laboratories Phils Inc maintains only 1.89% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Euro-Med Laboratories Phils Inc Industry Peers by Asset Resilience Ratio

Compare Euro-Med Laboratories Phils Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
AGP Ltd
KAR:AGP
Pharmaceuticals 0.71%
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
Pharmaceuticals 4.82%
DongKoo Bio&Pharma Co. Ltd
KQ:006620
Pharmaceuticals 4.28%
NatureCell Co.Ltd
KQ:007390
Pharmaceuticals 0.00%
Sam-A Pharm. Co. Ltd
KQ:009300
Pharmaceuticals 34.37%
Kyung Dong Pharmaceutical Co. Ltd
KQ:011040
Pharmaceuticals 5.22%
WooGene B&G Co. Ltd
KQ:018620
Pharmaceuticals 3.35%
Oscotec Inc
KQ:039200
Pharmaceuticals 61.00%

Annual Asset Resilience Ratio for Euro-Med Laboratories Phils Inc (2016–2022)

The table below shows the annual Asset Resilience Ratio data for Euro-Med Laboratories Phils Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 1.89% ₱190.60 Million ₱10.06 Billion -0.94pp
2021-12-31 2.83% ₱274.47 Million ₱9.69 Billion +0.61pp
2020-12-31 2.22% ₱224.03 Million ₱10.07 Billion -2.03pp
2019-12-31 4.25% ₱439.53 Million ₱10.34 Billion +0.76pp
2018-12-31 3.49% ₱337.27 Million ₱9.67 Billion -0.18pp
2016-12-31 3.67% ₱340.51 Million ₱9.28 Billion --
pp = percentage points